Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Imaging Studies III: Computed Tomography01:27

Imaging Studies III: Computed Tomography

248
DefinitionComputed Tomography (CT) of the genitourinary (GU) tract is a non-invasive imaging modality that utilizes X-rays and computer processing to generate detailed cross-sectional images of the urinary system, encompassing the kidneys, ureters, bladder, and adjacent structures such as the adrenal glands.PurposeCT scans of the GU tract serve several diagnostic and therapeutic purposes, including:Diagnosis of Urinary Tract Diseases: Detects kidney stones, tumors, cysts, and congenital...
248
Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

212
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
212
Brain Imaging01:14

Brain Imaging

623
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
623
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

456
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
456
Imaging Studies I: CT and MRI01:14

Imaging Studies I: CT and MRI

752
Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
752

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aging and metabolism contribute separately to brain-body health.

PLoS biology·2026
Same author

Amyloid and tau pathologies are drivers of white matter damage in aging and Alzheimer's disease.

GeroScience·2026
Same author

Data-driven subtyping and staging of ALS: A multicenter, longitudinal, deformation-based morphometry study.

Imaging neuroscience (Cambridge, Mass.)·2026
Same author

EXPRESS: Effects of prolonged fixation on vascular biomarkers in postmortem human brains.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026
Same author

Tau extent outperforms tau load as a predictor of neurodegeneration in Alzheimer's disease.

Molecular neurodegeneration·2026
Same author

Multimodal axes reveal individualized amyloid- <math><mi>β</mi></math> , tau, and neurodegeneration coupling in aging and Alzheimer's disease.

medRxiv : the preprint server for health sciences·2026
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
See all related articles

Related Experiment Video

Updated: Jan 7, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

743

Alzheimer's Imaging Consortium.

Veronika Pak1, Joon Hwan Hong1, Gleb Bezgin1

  • 1McGill University, Montreal, QC, Canada.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 23, 2025
PubMed
Summary
This summary is machine-generated.

This study maps whole-brain cell-cell interactions to explain atrophy in 13 neurodegenerative conditions. Key ligand-receptor pairs, particularly involving astrocytes and neurons, highlight pathways like axon guidance and Alzheimer's disease, offering therapeutic targets.

More Related Videos

Visualization of Amyloid &#946; Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

11.0K
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.8K

Related Experiment Videos

Last Updated: Jan 7, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

743
Visualization of Amyloid &#946; Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

11.0K
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.8K

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genomics

Background:

  • Cellular communication disruptions (neuron-glia-vascular) drive neuroinflammation, vascular issues, and neuronal death in neurodegeneration.
  • Understanding cell-cell interactions is crucial for predicting neurodegenerative disease progression and atrophy patterns.

Purpose of the Study:

  • To identify whole-brain cell-cell interactions that explain atrophy patterns in 13 distinct neurodegenerative conditions.
  • To uncover the specific ligand-receptor (LR) pairs and signaling pathways involved in neurodegeneration-associated brain atrophy.

Main Methods:

  • Generated 1,050 whole-brain neuroimaging maps of LR interactions across six cell types (neurons, astrocytes, microglia, oligodendrocytes, OPCs, endothelial cells).
  • Inferred LR pairs from post-mortem human brain gene expression data (Allen Human Brain Atlas).
  • Utilized Partial Least Squares Regression (PLS) to link LR communication patterns to atrophy maps of 13 neurodegenerative diseases (e.g., Alzheimer's, FTLD, PD, ALS).

Main Results:

  • The COL1A1-CD36 interaction and CD36-associated pairs were dominant in explaining atrophy patterns, accounting for significant covariance.
  • Atrophy patterns in frontotemporal lobar degeneration (FTLD), early- and late-onset Alzheimer's disease (EOAD/LOAD) most strongly contributed to the identified communication patterns.
  • Top LR pairs revealed significant bidirectional signaling between astrocytes and neurons, alongside neuron-microglia and neuron-neuron signaling, enriched in pathways like Slit/Robo axon guidance and the Alzheimer's presenilin pathway.

Conclusions:

  • Identified critical whole-brain LR interactions in neuron-astrocyte, neuron-microglia, and neuron-neuron signaling pathways underlying atrophy in neurodegenerative diseases.
  • Highlighted specific ligand-receptor pairs and pathways (e.g., Slit/Robo, presenilin) as potential therapeutic targets.
  • Advanced the understanding of molecular mechanisms driving brain atrophy in diverse neurodegenerative conditions.